{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"TERT is an enzyme that functions to maintain telomere length and genomic stability. The TERT promoter is frequently mutated in various cancer types.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"12/21/2022",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "24657534",
        "25048572",
        "23530248",
        "23348506",
        "23348503",
        "23887589"
      ]
    },
    "description":"TERT promoter mutations are able to reactivate TERT transcription by creating de novo consensus binding sites for the ETS family of transcription factors (PMID: 23348506, 23348503, 23530248, 23887589, 24657534).TERT promoter mutations have been widely associated with advanced forms of cancer and metastatic disease (PMID: 23348506, 23530248, 25048572). The former points to TERT promoter mutations as a potential biomarker of disease severity, and constitutes the first example of a prevalent pan-cancer, somatic mutation lying in a gene regulatory region.",
    "knownEffect":"Likely Gain-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"Promoter",
    "alterationType":null,
    "consequence":"upstream_gene_variant",
    "entrezGeneId":7015,
    "hgvs":"5:g.1295084A>C",
    "hugoSymbol":"TERT",
    "id":null,
    "proteinEnd":null,
    "proteinStart":null,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":true,
  "variantSummary":"Select hotspot mutations in the TERT promoter have been shown to be oncogenic.",
  "vus":false
}